MYIA
AMED

Mount Yale Investment Advisors’s Amedisys AMED Stock Holding History

Mount Yale Investment Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-465
Closed -$45.8K – 714
2025
Q2 		$45.8K Buy
+465
New +$44K ﹤0.01% 839
2018
Q4 		– Sell
-813
Closed -$96K – 335
2018
Q3 		$96K Sell
813
-401
-33% -$44.3K 0.02% 456
2018
Q2 		$104K Sell
1,214
-1,295
-52% -$95.1K 0.02% 445
2018
Q1 		$151K Buy
+2,509
New +$143K 0.03% 336

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mount Yale Investment Advisors's AMED Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 465 shares — an estimated $45.8K sold.

Mount Yale Investment Advisors first reported a position in AMED in Q1 2018 and held it in 4 quarters. The position peaked at $151K in Q1 2018. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Mount Yale Investment Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 465 Amedisys shares in Q3 2025, an estimated $45.8K.
  • Mount Yale Investment Advisors first reported a position in Amedisys in Q1 2018 and held it in 4 quarters.
  • Mount Yale Investment Advisors's Amedisys position peaked at $151K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.